Bristol-Myers Squibb (BMY) reports higher Q1 profit; revenue down 3%
Biotechnology company Bristol Myers Squibb (NYSE: BMY) said its first-quarter adjusted earnings increased modestly, despite a decline in revenues. Net income attributable to shareholders was $2.26 billion or $1.07 per […]
The post Bristol-Myers Squibb (BMY) reports higher Q1 profit; revenue down 3% first appeared on AlphaStreet.